Zobrazeno 1 - 10
of 5 551
pro vyhledávání: '"Xi CHENG"'
Publikováno v:
ACS Omega, Vol 9, Iss 38, Pp 39792-39803 (2024)
Externí odkaz:
https://doaj.org/article/8c006c3e9499458cbfddafaacd0e7046
Publikováno v:
Shuiwen dizhi gongcheng dizhi, Vol 51, Iss 5, Pp 182-194 (2024)
Due to the influence of extreme rainfall and high intensity human engineering activities, the advance speed of the gully head in the Loess Tableland is intensified, which seriously threatens the economic and social development of the Loess Tableland.
Externí odkaz:
https://doaj.org/article/0333917fc1c84874ae25ac785ca491b7
Autor:
Wenjuan Tian, Yulan Ren, Jing Lu, Chuyu Jing, Wei Zhang, Haiming Li, Tingting Wang, Zhiguo Hou, Ting Yang, Wenqing Zhu, Yi Zhang, Boer Shan, Huijuan Yang, Xi Cheng, Huaying Wang
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background The combination of anti-programmed death 1 (PD-1) inhibitors and tyrosine kinase inhibitors is an effective treatment strategy in endometrial cancer. We aimed to explore the efficacy and safety of camrelizumab plus apatinib as an
Externí odkaz:
https://doaj.org/article/add83a36851b4bfe963c2d118c5077c9
Publikováno v:
BMC Pregnancy and Childbirth, Vol 24, Iss 1, Pp 1-16 (2024)
Abstract Background The pregnant women with intrahepatic cholestasis were at high risk of fetal distress, preterm birth and unexpected stillbirth. Intrahepatic cholestasis of pregnancy (ICP) was mainly caused by disorder of bile acid metabolism, wher
Externí odkaz:
https://doaj.org/article/0a22822c670f4c50ae87a94566234f59
Autor:
Miao Zheng, Bo Feng, Yumin Zhang, Xin Liu, Na Zhao, Hui Liu, Zichao Xu, Xinheng He, Zhiyan Qu, Shizhao Chen, Zhidong Jiang, Xi Cheng, Hong Liu, Yi Zang, Linxiang Zhao, Jie Zheng, Leike Zhang, Jia Li, Yu Zhou
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 14, Iss 7, Pp 3286-3290 (2024)
Externí odkaz:
https://doaj.org/article/0507dae3bcfe403cb289ec049acee92e
Autor:
Xinheng He, Lifen Zhao, Yinping Tian, Rui Li, Qinyu Chu, Zhiyong Gu, Mingyue Zheng, Yusong Wang, Shaoning Li, Hualiang Jiang, Yi Jiang, Liuqing Wen, Dingyan Wang, Xi Cheng
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract As the most abundant organic substances in nature, carbohydrates are essential for life. Understanding how carbohydrates regulate proteins in the physiological and pathological processes presents opportunities to address crucial biological p
Externí odkaz:
https://doaj.org/article/f09ba2c370cc4208899023e31dad4830
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-19 (2024)
Abstract Background Inherited variations in DNA double-strand break (DSB) repair pathway are known to influence ovarian cancer occurrence, progression and treatment response. Despite its significance, survival-associated genetic variants within the D
Externí odkaz:
https://doaj.org/article/44b311a2d8f540fdb61b03090e943cce
Autor:
Qiankun Zuo, Zhengkun Shi, Bo Liu, Na Ping, Jiangtao Wang, Xi Cheng, Kexin Zhang, Jia Guo, Yixian Wu, Jin Hong
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
IntroductionRetinal diseases significantly impact patients’ quality of life and increase social medical costs. Optical coherence tomography (OCT) offers high-resolution imaging for precise detection and monitoring of these conditions. While deep le
Externí odkaz:
https://doaj.org/article/3327d85ed25849e4812003a25d21b6de
Autor:
Qianqian Zhang, Wenping Yang, Yun Qian, Yu Zhang, Huihui Zhao, Mingzhu Shu, Qingyang Li, Yanan Li, Yu Ding, Shiyu Shi, Yaxi Liu, Xi Cheng, Qi Niu
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionAutoimmune encephalitis (AE) comprises a group of inflammatory brain disorders mediated by autoimmune responses. Anti–N-methyl-D-aspartate receptor (NMDAR) encephalitis, anti–leucine-rich glioma-inactivated 1 (LGI1) encephalitis, and
Externí odkaz:
https://doaj.org/article/eb33e227de1e4e28972b8d0e3ea1f25a
Autor:
Haosheng Li, Haoran Feng, Tao Zhang, Junwei Wu, Xiaonan Shen, Shuiyu Xu, Lianghui Xu, Shaodong Wang, Yaqi Zhang, Wenqing Jia, Xiaopin Ji, Xi Cheng, Ren Zhao
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-19 (2024)
Abstract Background Tyrosine kinase inhibitors (TKIs) are crucial in the targeted treatment of advanced colorectal cancer (CRC). Anlotinib, a multi-target TKI, has previously been demonstrated to offer therapeutic benefits in previous studies. Circul
Externí odkaz:
https://doaj.org/article/7222a2371c10408d9175bac8799a2b03